President and CEO of Genomic Health Inc (30-Year Financial, Insider Trades) Kimberly J Popovits (insider trades) sold 50,000 shares of GHDX on 08/13/2019 at an average price of $73.76 a share. The total sale was $3.7 million.
Genomic Health Inc is a healthcare company. It provides genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early stage cancer. Genomic Health Inc has a market cap of $2.79 billion; its shares were traded at around $74.70 with a P/E ratio of 57.02 and P/S ratio of 6.71. GuruFocus has detected 1 severe warning sign with Genomic Health Inc. .
CEO Recent Trades:
- President and CEO Kimberly J Popovits sold 50,000 shares of GHDX stock on 08/13/2019 at the average price of $73.76. The price of the stock has increased by 1.27% since.
- President and CEO Kimberly J Popovits sold 50,000 shares of GHDX stock on 08/09/2019 at the average price of $73.76. The price of the stock has increased by 1.27% since.
CFO Recent Trades:
- CFO G Bradley Cole sold 60,000 shares of GHDX stock on 08/12/2019 at the average price of $73.31. The price of the stock has increased by 1.9% since.
Directors and Officers Recent Trades:
- Chief Commercial Officer James J Vaughn sold 4,500 shares of GHDX stock on 08/08/2019 at the average price of $73.74. The price of the stock has increased by 1.3% since.
- Chief Scientific Officer Steven Shak sold 50,000 shares of GHDX stock on 08/06/2019 at the average price of $71.83. The price of the stock has increased by 4% since.
- Chief People Officer Kim Mceachron sold 12,103 shares of GHDX stock on 08/05/2019 at the average price of $71.53. The price of the stock has increased by 4.43% since.
- Chief Scientific Officer Steven Shak sold 50,000 shares of GHDX stock on 08/02/2019 at the average price of $72.65. The price of the stock has increased by 2.82% since.
For the complete insider trading history of GHDX, click here
.
